Newborn screening for inborn errors of metabolism in Japan: A history of the development of newborn screening

Pediatric Endocrinology Reviews

Volumn 10, Issue SUPPL. 1, 2012, Pages 8-25

  Kitagawa, Teruo ^a  

^a Tokyo Association of Health Service   (Japan)

Author keywords

Amino acid metabolism; Fatty acid metabolism; Inborn errors of metabolism; Newborn screening; Organic acid metabolism; Outcome surveys; Tandem mass spectrometry; Treatment guidelines

Indexed keywords

CYSTEINE; DEXTRIN; GALACTOSE; GLUCOSE; ISOLEUCINE; LACTOSE; LEUCINE; METHIONINE; PHENYLALANINE; PYRIDOXINE; VALINE;

ARTIFICIAL MILK; BLOOD SAMPLING; CHILD DEVELOPMENT; CHILDHOOD; CLINICAL EXAMINATION; DIAGNOSTIC TEST; DIET THERAPY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; GALACTOSEMIA; GENETIC ANALYSIS; HEALTH CARE ORGANIZATION; HISTIDINEMIA; HOMOCYSTINURIA; HUMAN; INBORN ERROR OF METABOLISM; INCIDENCE; INTELLIGENCE QUOTIENT; JAPAN; JAPANESE; MAPLE SYRUP URINE DISEASE; MEDICAL HISTORY; NEWBORN SCREENING; ONSET AGE; PATHOPHYSIOLOGY; PHENYLKETONURIA; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; URINALYSIS;

HEALTH PLANNING GUIDELINES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT, NEWBORN; JAPAN; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; PRACTICE GUIDELINES AS TOPIC;

EID: 84871235734     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Følling A. Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Hoppe-Seylers Z Physiol. Chem. 1934;277:169-176 (in German)
2. Jervis GA, Block RJ, Bolling D, Kanze E. Chemical and metabolic studies on phenylalanine: II. The phenylalanine content of the blood and spinal fluid in phenylpyruvic oligophrenia. J Biol Chem 1940;134:105-113
3. Jervis GA. Phenylpyruvic oligophrenia: Deficiency of phenylalanine- oxidizing system. Proc Soc Exp Biol Med 1953;82:514-515
4. Bickel H, Gerrard J, Hickmans EM. Influence of phenylalanine intake on phenylketonuria. Lancet. 1953;2:812-813
5. Bickel H, Gerrard J, Hickmans EM. The influence of phenylalanine intake on the chemistry and behaviour of a Phenylketonuric child. Acta Paediatr Scand 1954;43:64-77
6. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-343.
7. Guthrie R. The introduction of newborn screening for phenylketonuria. A personal history. Eur J Pediatr 1996;155(Suppl 1):S4-5 (Pubitemid 26262496)
8. Kitagawa T. People who created and developed diet therapy for phenylketonuria. Bulletin on Special Formula 2003; 39:3-6 (in Japanese)
9. Oura T. The time when domestic low-phenylalanine milk was produced. Bulletin on Special Formula 1981; 2:39-41 (in Japanese)
10. Naruse H. National screening in Japan. Past and present. Jap Soc Mass Scr 1998;8(Suppl 1):17-27
11. Kitagawa T, Masuko N, Ishihara S. Mass-screening for inherited metabolic diseases: Methods and some comment. Shonika Rinsho 1974;27:1276-1287 (in Japanese)
12. Beutler E, Baluda MC. A simple spot screening test for galactosemia. J Lab Clin Med 1966;68:137-141
13. Paigen K, Pacholec F, Levy HL. A new method of screening for inherited disorders of galactose metabolism. J Lab Clin Med 1982;99:895-907 (Pubitemid 12081553)
14. Kitagawa T. The system of newborn mass-screening in Massachusetts in the United States. Sanfujinka no Sekai 1974; 26:1251-1258 (in Japanese)
15. Levy HL, Madigan PM, Shin VE. Massachusetts metabolic disorders screening program. I. Technics and results of urine screening. Pediatrics. 1972;49:825-836
16. Massachusetts Department of Public Health. Cost-benefit analysis of newborn screening for metabolic disorders. N Engt J Med 1974;291:1414-1416
17. Komrower GM. The philosophy and practice of screening for inherited diseases. Pediatrics. 1974;53:182-188
18. Kitagawa T. Cost-benefit balance of newborn mass-screening for inherited metabolic diseases in Japan. No to Hattatsu 1975;7:235-240 (in Japanese)
19. Guthrie R. Screening for "inborn errors of metabolism" in the newborn infant-a multiple test program. Birth Defects Orig Artic Ser 1968;4:92-98
20. Moriyama Y. Research group of screening for metabolic diseases: New beginning. Taishaijo Screening Kenkyukai Kaiho 1976;1:1 (in Japanese)
21. Moriyama Y. Ministry of Health and Welfare Genetic Research Group of Physical and Mental Disabilities. Genetic research of physical and mental disability prevention (Lead researcher: Eiji Inoue). Kenkyu Hokoku 1975 (in Japanese)
22. Tada K, Oura T, Kitagawa T, Matsuda I, Kawamura M, Wada Y. Treatment guidelines for inherited metabolic disease-Target diseases in newborn mass-screening. J Jpn Ped Soc 1977; 81:840-845 (in Japanese)
23. Committee for Homocystinuria Treatment Guideline Revision. Partial revision of treatment guideline for homocystinuria. Bulletin on Special Formula 1996;32:67-68 (in Japanese)
24. Ghadimi H, Partington MW, Hunter A. A familial disturbance of histidine metabolism. N Engl J Med 1961;265:221-224
25. Kitagawa T. Announcement of the Ministry of Health and Welfare about screening for inborn errors of metabolism. Deletion of histidinemia from the target disease list of specific pediatric chronic diseases. Bulletin on Special Formula 1992;25:72-76 (in Japanese)
26. Moriyama Y. Announcement of the establishment of the Japan Cooperative Project on Special Formula and request for collaboration. Bulletin on Special Formula1980;1:4 (in Japanese)
27. Aoki K, Ogushi Y. Follow-up survey of outcome of the patients detected by newborn screening and treated with special formula registered in 1983(exclusive of five diseases). Bulletin on Special Formula 1984;9:40-47 (in Japanese)
28. Kitagawa T. Food Exchange List for Phenylketonuria - Dietary Therapy. Imperial Gift Foundation Maternal/Child health center Special Formula Office 1989 (in Japanese)
29. Committee of the Japan Cooperative Project on Special Formula. Diet therapy guide book for inborn errors of amino acid metabolism. Boshi Aiikukai Maternal/Child health center Special Formula Office 1998 (in Japanese)
30. Committee of the Japan Cooperative Project on Special Formula. Revised diet therapy guide book for inborn errors of amino acid metabolism. Imperial Gift Foundation Boshi Aiikukai 2004 (in Japanese)
31. Aoki K, Ito K. Report of follow-up survey of five diseases-School attendance of patients detected by screening. Bulletin on Special Formula 1992;24:25-28 (in Japanese)
32. Owada M, Abe N, Watanabe S, Suzuki N. Research on treatment for phenylketonuria and benign hyperphenylalaninemia. Shonika 1992;33:867-875 (in Japanese)
33. Committee for Revision of PKU Treatment Guideline. Revision of treatment guideline for phenylketonuria (including a part of hyperphenylalaninemia) and 1995 revision of treatment recommendation. Bulletin on Special Formula 1995;30:43-49 (in Japanese)
34. Committee for Revision of PKU Treatment Guideline. A report of revised treatment guideline for phenylketonuria (including a part of hyperphenylalaninemia). J Jpn Ped Soc 1995;99:1535-1539 (in Japanese)
35. Burgard P. Development of intelligence in early treated phenylketonuria. Eur J Pediatr 2000;159 (Suppl 2): S74-S79
36. Schweitzer-Krantz S, Burgard P. Survey of national guidelines for the treatment of phenylketonuria. Eur J Pediatr 2000;159(Suppl 2):S70-S73
37. Aoki K, Kinoshita K, Hayashi K. Research on follow-up survey of newborn mass-screening. Bulletin on Special Formula 2000;36:50-60 (in Japanese)
38. Smith I, Clayton BE, Walff OH. New variation of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet 1976;1:1108-1111
39. Kaufman S, Holtzman NA, Milstien S, Butler LJ, Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. New Engl J Med 1975;293:785-790
40. Review committee of an interim recommended guideline for the treatment of BH4 deficiency. Interim recommended guideline for treatment of tetrahydrobiopterin deficiency. Bulletin on Special Formula 1996;32:53-66 (in Japanese)
41. Fukushima T, Nixson JC. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980;102:176-188 (Pubitemid 10099498)
42. Suzuki K, Owada M. A simple and sensitive method for the determination of pterins in cerebrospinal fluid. Clinical usefulness for management of tetrahydrobiopterin deficiency. J Inher Metab Dis 1991;14:825-830
43. Arai N, Narisawa K, Hayakawa H, Tada K. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assay on dried blood spots. Pediatrics 1982;70:426-430 (Pubitemid 12052289)
44. Blau N, Thöny B, Cotton RGH, Hyland K. Disorder of tetrahydrobiopterin and related biogenic amines. In: The Metabolic and Molecular Basis of Inherited Disease Vol 2, 8th ed. Editors Scriver CR et al. New York: McGrow Hill Inc., 2001;1725-1776
45. Kure S, Hou DC, Ohura T, Iwamoto H, Suzuki S, Sugiyama N, Sakamoto O, Fujii K, Matsubara Y, Narisawa K. Tetrahydrobiopterin-responsive phenylalanine hydrosxylase deficiency. J Pediatr 1999;135:375-378
46. Matsubara Y, Kure S, Ohura T. Second research report from the committee for treatment guideline for BH4-responsive hyperphenylalaninemia. Bulletin on Special Formula 2002;38:44-59 (in Japanese)
47. Shintaku H. Single-dose administration test of BH4. Shoninaika 2006;38:1326-1332 (in Japanese)
48. Shintaku H. Diagnosis and treatment of BH4-responsive mild phenylketonuria. Bulletin on Special Formula 2007;43:11-16 (in Japanese)
49. Kure S. BH4-responsive phenylalanine hydroxylase deficiency: From the establishment of disease concept to treatment. Bulletin on Special Formula 2007;43:8-10 (in Japanese)
50. Aoki K, Kinoshita K. Four diseases identified by newborn mass-screening: Adolescent patients and their current status. Bulletin on Special Formula 2002;38:24-28 (in Japanese)
51. Maternal/Child Healthcare Center, Imperial Gift Foundation Boshi-Aiiku-Kai. Chapter 3: Follow-up survey of patients identified by newborn mass-screening in Japan. In: History of the Japan Cooperative Project on Special Formula, Tokyo: Special Formula Office, 1993; pp24-34 (in Japanese)
52. Hisashige A. Research on technology assessment of mass-screening system. In: 1993 Ministry of Health and Welfare research of physical and mental disabilities: Research on evaluation method of mass-screening system (Lead researcher: Yasuhiro Kuroda). Tokyo: Ministry of Health and Welfare, 1994; 63-67 (in Japanese)
53. Hisashige A. Health economic analysis of the neonatal screening program in Japan. Int J Technol Assess Health Care 1994;10:382-391 (Pubitemid 24222538)
54. Okusa Y. Sugawara T, Yamaguchi S. Cost-benefit analysis of newborn mass-screening by tandem mass spectrometry. J Jpn Soc for Mass-Screening 2007;17:35 (in Japanese)
55. Aoki K. Current status of the follow-up survey of newborn mass-screening. Bulletin on Special Formula 1996;32:42-52 (in Japanese)
56. Aoki K, Matsuda I, Tada K, Oura T, Kitagawa T, Maruyama H, Owada M. Reassessment of follow-up system for the patients detected by newborn mass-screening. Bulletin on Special Formula 2002;38:21-23 (in Japanese)
57. Owada M, Abe N, Yokoyama M, Usui H. Treatment for adult patients with phenylketonuria: Experience of 20 patients. Bulletin on Special Formula 2011;47:25-30 (in Japanese)
58. Yoshino N, Watanabe J, Okada J. Medical and social outcomes of adult phenylketonuria patients. Bulletin on Special Formula 2011;47:6-7 (in Japanese)
59. Mochizuki H, Yamaguchi S. Adult male phenylketonuria patients leading productive social lives. Bulletin on Special Formula 2011;47:35-37 (in Japanese)
60. Shigematsu Y, Hata I, Tanaka Y, Sudo M. Fundamental investigation of newborn mass-screening by electrospray tandem mass spectrometry: Diagnosis of inborn error of organic acid metabolism, Ministry of Health and Welfare research of physical and mental disabilities: Research on effective mass-screening practice (Lead researcher: Tsugutoshi Aoki). 1996 Kenkyu Hokokusho 1996;197-200 (in Japanese)
61. Yamaguchi S. Research on 21st-century newborn mass-screening in Japan. Child and family research project by the Welfare, Labour and Science Research Subsidy 2004 (Lead researcher: Seiji Yamaguchi) Kenkyu Hokokusho. 2004;3-10 (in Japanese)
62. Kitagawa T. Newborn mass-screening by tandem mass spectrometry: Preparation and results of trial run. Annual Report of Tokyo Health Service Association 2012;41:137-144 (in Japanese)
63. Shigematsu Y. Accuracy improvement of tandem mass spectrometry and its maintenance. Research on target diseases for mass-screening. Research project by the Welfare, Labour and Science Research Subsidy. Research on preparation for and quality improvement of newborn mass-screening by tandem mass spectrometry (Lead researcher: Seiji Yamaguchi). 2010 Kenkyu Hokokusho 2011;49-60 (in Japanese)
64. Yamaguchi S. New neonatal mass-screening by tandem mass spectrometry Q and A 2012. Tokyo: Welfare, Labour and Science Research. Newborn mass-screening by tandem mass spectrometry research: Preparation and quality improvement in 2012 (in Japanese)
65. Kitagawa T. 2011 Meeting for special formula for treatment of IEM: Development and improvement, First session of joint research report. How to treat to the patients detected by newborn mass-screening using tandem mass spectrometry. Bulletin on Special Formula 2011;47:40-48 (in Japanese)